US Stock MarketDetailed Quotes

CLLS Cellectis

Watchlist
  • 1.960
  • +0.090+4.81%
Close Nov 25 16:00 ET
  • 1.960
  • 0.0000.00%
Post 20:01 ET
196.18MMarket Cap-1675P/E (TTM)

About Cellectis Company

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Company Profile

SymbolCLLS
Company NameCellectis
Listing DateMar 25, 2015
Issue Price36.83
Founded1999
CEODr. Andre Choulika
MarketNASDAQ
Employees221
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address8, rue de la Croix Jarry
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75013
Phone33-1-81-69-16-00
Websitehttp://www.cellectis.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Andre Choulika
  • Director and Chief Executive Officer
  • 1.13M
  • Dr. David Sourdive
  • Director, Deputy Chief Executive Officer and Executive Vice President, CMC and Manufacturing
  • 657.84K
  • Bing Wang, PhD
  • Chief Financial Officer
  • --
  • Stephan Reynier
  • Chief Regulatory and Pharmaceutical Compliance Officer
  • --
  • Dr. Mark Frattini, M.D.,PhD
  • Chief Medical Officer
  • --
  • Kyung Nam-Wortman
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Philippe Duchateau, PhD
  • Chief Scientific Officer
  • --
  • Arthur Stril
  • Chief Business Officer
  • --
  • Dr. Steven Doares, PhD
  • Senior Vice President, US Manufacturing
  • --
  • Dr. Jean-Pierre Garnier, PhD
  • Chairman of the Board
  • 203.80K
  • Laurent Arthaud
  • Director
  • --
  • Cecile Chartier
  • Independent Director
  • 47.77K
  • Dr. Donald A. Bergstrom, M.D.,PhD
  • Independent Director
  • 102.75K
  • Pierre Tristan Michel Bastid
  • Independent Director
  • 97.34K
  • Axel-Sven Malkomes
  • Independent Director
  • 102.75K
  • Rainer J. Boehm, M.B.A.
  • Independent Director
  • 99.60K
  • Marie-Bleuenn Terrier
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data